The company repurchased $700 million of common stock during the six months ended June 30, 2024, indicating a continued commitment to returning capital to shareholders. A new share repurchase authorization was approved in July 2024 for up to $3.3 billion effective August 1, 2024 to December 31, 2026.

Global specialty written premium increased driven by written price increases across almost all lines as well as an increase in gross new business, primarily in wholesale. This shows that the company is expanding in global markets.

The underlying combined ratio in Commercial Lines improved to 87.4% from 88.3%, and in Personal Lines improved to 96.7% from 101.7%. This indicates improved underwriting profitability.

The expense ratio in Commercial Lines increased to 31.1% from 31.3% and in Personal Lines increased to 26.4% from 25.7%. This indicates a slight increase in operational costs.

The document mentions uncertainties related to sexual molestation and sexual abuse claims, which are a known risk factor for insurance companies. This indicates a potential ongoing liability.

The document mentions the impacts of changing climate and weather patterns on the business, operations and investment portfolio including on claims, demand and pricing of products. This indicates a risk of increased claims and costs due to climate change.

The document mentions the potential for losses due to our reinsurers' unwillingness or inability to meet their obligations under reinsurance contracts and the availability, pricing and adequacy of reinsurance to protect the Company against losses. This indicates a risk of increased costs and potential losses if reinsurers fail to meet their obligations.

The document mentions that most of Personal Lines written premium is associated with the exclusive licensing agreement with AARP, which is effective through December 31, 2032. This agreement provides an important competitive advantage given the size of the 50 plus population and the strength of the AARP brand.

The company repurchased $700 million of common stock during the six months ended June 30, 2024, indicating a continued commitment to returning capital to shareholders. A new share repurchase authorization was approved in July 2024 for up to $3.3 billion effective August 1, 2024 to December 31, 2026.